Scientist II, Process Development, Downstream

Job description:

AtOXB, our people are at the heart of everything we do. We’re on a mission to enable life-changing therapies to reach patients around the world—and we’re looking for passionate individuals who embody our core values every day:Responsible, Responsive, Resilient, and Respectful.

We’re currently recruiting for aScientist II Process Development Scientist to join our Process Development Team. In this role, you will perform and report laboratory-based experiments or investigations in accordance with scientific or regulatory requirements in line with departmental objectives, playing a key part in advancing our mission and making a real difference.

Your responsibilities in this role would be:

• Involvement in activities ranging from vector production at laboratory and pilot scales, process development and optimisation, technology transfer, and process characterization activities associated with the manufacture of new gene therapy vectors.

• Execute downstream vector purification and vector formulation activities for scale-up/scale-down of existing bioprocesses under the direction of the Team Leader or a senior scientist and in accordance with correct methodologies and procedures.

• Prepare written reports to a high standard and present data within the PD group.

• Liaise with other members of the PD group and assist with other development activities where appropriate.

• Ensure a high standard of record keeping and documentation of experiments and investigations.

• Support the writing of departmental risk assessments, SOPs, and other documentation where appropriate.

We are looking for:

• A minimum of a BSc Degree and/or relevant experience

• Practical experience and sound understanding of downstream purification principles and processes is desired.

• Pharmaceutical industry experience in biological research and development or equivalent experience gained elsewhere desirable, but not necessary.

• Experience with the operation of laboratory, pilot or production scale downstream purification processes is desirable, but not necessary.

• Competency in data capture, reporting, and writing.

• The capability of explaining clearly why an experiment is being conducted and how the experiments help the group meet their objectives.

• Some knowledge of regulatory requirements e.g. GMP, GLP, GCP and/or Validation and Quality Management systems.

• Familiarity with data analysis software packages such as Microsoft Excel, JMP, Design Expert, GraphPad Prism

• Fluency in written and spoken English.

Profile description:

About Us:

OXB is a quality and innovation-led viral vector CDMO with a mission to enable its clients to deliver life changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, we have more than 25 years of experience in viral vectors; the driving force behind the majority of gene therapies.

OXB collaborates with some of the world’s most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. OXB’s world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods, and depth of regulatory expertise.

Why Join Us?

• Competitive total reward packages

• Wellbeing programmesthat support your mental and physical health

• Career development opportunitiesto help you grow and thrive

• Supportive, inclusive, and collaborative culture

• State-of-the-art labs and manufacturing facilities

• A company that lives its values:Responsible, Responsive, Resilient, Respect

We want you to feel inspired every day. At OXB, we’re future-focused and growing fast. We succeed together—through passion, commitment, and teamwork.

Ready to Make a Difference?

Collaborate. Contribute. Change lives.

We offer:

Oxford Biomedica is a quality and innovation-led viral vector CDMO that enables its clients to deliver life-changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, Oxford Biomedica has more than 25 years of experience in viral vectors, the driving force behind the majority of gene therapies.

Cell and gene therapy is the treatment of disease by the delivery of therapeutic genetic material (DNA or RNA), into a patient’s cells. One highly effective approach to delivering genetic information is to re-engineer existing viruses to be safe delivery vehicles (vectors) to insert the genetic material into patients’ cells. This can be achieved either by directly administering the vector to the patient (often referred to as in vivo gene therapy), or by first introducing the genetic material to cells or tissue outside of the body, before administering the cells or tissue into the patient (often referred to as ex vivo gene therapy or gene-modified cell therapy).

Oxford Biomedica collaborates with some of the world\’s most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedica\’s world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise.

#J-18808-Ljbffr